Level of serum VEGF in male breast cancer and its association with circulating tumor cells

Zhang Juliang,Yao Qing,Chen Jianghao,Wang Ting,Wang Hui,Fan Jing,Ling Rui,Yi Jun,Yuan Shifang,Wang Ling
DOI: https://doi.org/10.3969/j.issn.1672-4992.2013.03.29
2013-01-01
Journal of Modern Oncology
Abstract:Objective:To explore the level of serum VEGF in male breast cancer and its clinical significance as well as the relationship with peripheral blood circulating tumor cells in the patients.Methods:Level of serum VEGF in 8 cases of healthy male volunteer and 18 cases of breast cancer were detected by ELISA.CK19 mRNA in peripheral blood was detected by qRT-PCR as an index of circulating tumor cells in the patients as well.Correlation between serum VEGF level and peripheral blood circulating tumor cells was analyzed.Results:Level of serum VEGF in male breast cancer were significantly higher compared with those in healthy volunteer(P=0.015).A subgroup analysis showed that in lymph node positive patients,level of serum VEGF were higher(P=0.026).CK19 mRNA was found in peripheral blood of 5 cases of male breast cancer and the positive rate was 27.8%.However,it was not detected in that of healthy volunteers.Mean level of serum VEGF in CK19 positive and negative patients was 130.34±77.18 pg/ml and 58.01±52.43pg/ml,respectively.There was a significant difference between the two groups(P=0.038).Conclusion:Level of serum VEGF in male breast cancer was closely related with the peripheral blood circulating tumor cells.High level of serum VEGF may be a soluble biomarker for the early micrometastasis of male breast cancer.
What problem does this paper attempt to address?